OpenVSafe by OpenVAERS
Search V-safe

ZC4-63547-13136

2 vaccinations 1 coded response 7 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
104 / NY
Registered
2021-02-11
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-01-14
    Dose 1 — Moderna
  2. 2021-02-11
    Registered in v-safe
  3. 2021-02-11
    Dose 2 — Moderna
  4. 2021-02-11
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Swelling · None
    Adult check-in
  7. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-08-12
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  10. 2022-02-11
    Survey response — 12 months, dose 2
    MedDRA: Ageusia, Anosmia, Pain — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Intense body aches Prolonged no smell/ taste for 3 months
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-02-11
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  12. 2022-02-16

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Moderna
22021-02-11Moderna

Call center

ReportedOutcomeVAERS-related outcome
2022-02-11 Unsuccessful

Free text

Release 11 — 12 months, dose 2

2022-02-11

Symptoms: Intense body aches Prolonged no smell/ taste for 3 months

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDAnosmia · · ✓
SDPain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release